In 2023, Australia became the first country in the world to allow health-care professionals to use a psychedelic drug to ...
CLEVELAND, Ohio — A study by Ohio State University researchers suggests that adding a stellate ganglion block to cognitive ...
A retrospective study evaluated adults with both PTSD and depression who received a novel sequential bilateral TMS protocol from Family Care Center, which targets both sides of the brain. -- Patients ...
Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.
A new study led by researchers at the Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, suggests that using neurostimulation therapies on a specific brain ...
Kirstie Cummings, Ph.D., an assistant professor in the Department of Neurobiology, was recently honored with the Heersink School of Medicine's Featured Discovery Award. She was recognized alongside ...
Mental health conditions affect up to 20% of pregnant or postpartum women, according to the National Institutes of Health ...
Vancouver, Canada, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and ...
People frequently use medical cannabis to treat anxiety, depression and PTSD, but two new reviews show there is little ...
As a sophomore in high school, Greta had survived a school shooting in which three of her classmates died. She had trouble sleeping and focusing during the 3 months after the event and saw a therapist ...
Program supported by a $3.3M NIH/NIMH grant running through 2030. Training offered in 2026 across fire stations and EMS organizations in New York and Texas. Clinical trials aim to recruit 800 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results